Buchanan Lucas W. 4
4 · Silk Road Medical Inc · Filed Jul 31, 2023
Insider Transaction Report
Form 4
Buchanan Lucas W.
Chief Financial Officer
Transactions
- Award
Common Stock
2023-05-19$26.17/sh+507$13,268→ 206,082 total - Exercise/Conversion
Option (right to buy)
2023-07-28−2,000→ 5,331 totalExercise: $20.00From: 2019-05-03Exp: 2029-04-03→ Common Stock (2,000 underlying) - Exercise/Conversion
Option (right to buy)
2023-07-28−7,643→ 0 totalExercise: $1.60From: 2015-12-03Exp: 2025-12-03→ Common Stock (7,643 underlying) - Exercise/Conversion
Common Stock
2023-07-28$1.60/sh+7,643$12,229→ 213,725 total - Exercise/Conversion
Common Stock
2023-07-28$20.00/sh+2,000$40,000→ 215,725 total
Footnotes (2)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
- [F2]All of the shares subject to the option are fully vested and exercisable as of the date hereof.